Cargando…

Associations of Polygenic Risk Score for Late-Onset Alzheimer's Disease With Biomarkers

Late-onset Alzheimer's disease (LOAD) is a common irreversible neurodegenerative disease with heterogeneous genetic characteristics. Identifying the biological biomarkers with the potential to predict the conversion from normal controls to LOAD is clinically important for early interventions of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qiaojun, Lv, Xingping, Jin, Fei, Liao, Kun, Gao, Liyuan, Xu, Jiayuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047857/ https://www.ncbi.nlm.nih.gov/pubmed/35493930 http://dx.doi.org/10.3389/fnagi.2022.849443

Ejemplares similares

Phenome-Wide Association Study of Polygenic Risk Score for Alzheimer’s Disease in Electronic Health Records
por: Fu, Mingzhou, et al.
Publicado: (2022)

Radiomic Features of the Hippocampus for Diagnosing Early-Onset and Late-Onset Alzheimer’s Disease
por: Du, Yang, et al.
Publicado: (2022)

Erratum: Investigating the association between polygenic risk scores for Alzheimer's disease with cognitive performance and intrinsic functional connectivity in healthy adults
Publicado: (2023)

The role of ethnicity, biological sex, and psychotropic agents in early and late onset Alzheimer’s disease
por: Miller, Alyssa, et al.
Publicado: (2022)

Endophenotypic effects of the SORL1 variant rs2298813 on regional brain volume in patients with late-onset Alzheimer’s disease
por: Chen, Chun-Yu, et al.
Publicado: (2022)

An interpretable Alzheimer’s disease oligogenic risk score informed by neuroimaging biomarkers improves risk prediction and stratification
por: Suh, Erica H., et al.
Publicado: (2023)

Effects of copy number variations on longevity in late-onset Alzheimer’s disease patients: insights from a causality network analysis
por: Hao, Yanan, et al.
Publicado: (2023)

Polygenic risk scores for Alzheimer’s disease, and academic achievement, cognitive and behavioural measures in children from the general population
por: Korologou-Linden, Roxanna, et al.
Publicado: (2019)

Cognitive impairment in long-living adults: a genome-wide association study, polygenic risk score model and molecular modeling of the APOE protein
por: Kashtanova, D. A., et al.
Publicado: (2023)

Profiling the low-beta characteristics of the subthalamic nucleus in early- and late-onset Parkinson’s disease
por: Wu, Delong, et al.
Publicado: (2023)

Dementia-related genetic variants in an Italian population of early-onset Alzheimer’s disease
por: Bartoletti-Stella, Anna, et al.
Publicado: (2022)

Editorial: Neuroimaging Biomarkers and Cognition in Alzheimer's Disease Spectrum
por: Chen, Jiu, et al.
Publicado: (2022)

Polygenic Risk Score Effectively Predicts Depression Onset in Alzheimer’s Disease Based on Major Depressive Disorder Risk Variants
por: Upadhya, Suraj, et al.
Publicado: (2022)

Early‐onset Alzheimer's disease explained by polygenic risk of late‐onset disease?
por: Mantyh, William G., et al.
Publicado: (2023)

Genome-Wide Association Study of Alzheimer’s Disease Brain Imaging Biomarkers and Neuropsychological Phenotypes in the European Medical Information Framework for Alzheimer’s Disease Multimodal Biomarker Discovery Dataset
por: Homann, Jan, et al.
Publicado: (2022)

Emerging Electroencephalographic Biomarkers to Improve Preclinical to Clinical Translation in Alzheimer’s Disease
por: Cope, Zackary A., et al.
Publicado: (2022)

Exploration of novel biomarkers in Alzheimer’s disease based on four diagnostic models
por: Zou, Cuihua, et al.
Publicado: (2023)

Effect of renal function on the diagnostic performance of plasma biomarkers for Alzheimer’s disease
por: Zhang, Bin, et al.
Publicado: (2023)

Effects of preventive interventions on neuroimaging biomarkers in subjects at-risk to develop Alzheimer's disease: A systematic review
por: Perus, Lisa, et al.
Publicado: (2022)

Associations between blood-based biomarkers of Alzheimer’s disease with cognition in motoric cognitive risk syndrome: A pilot study using plasma Aβ42 and total tau
por: Chen, Pei-Hao, et al.
Publicado: (2022)

PSEN1 c.1292C<A Variant and Early-Onset Alzheimer’s Disease: A Scoping Review
por: Orozco-Barajas, Maribel, et al.
Publicado: (2022)

Impact prediction of translocation of the mitochondrial outer membrane 70 as biomarker in Alzheimer's disease
por: Cao, Xi, et al.
Publicado: (2022)

Corrigendum: Associations between blood-based biomarkers of Alzheimer's disease with cognition in motoric cognitive risk syndrome: A pilot study using plasma Aβ42 and total tau
por: Chen, Pei-Hao, et al.
Publicado: (2023)

Depressive Symptoms Have Distinct Relationships With Neuroimaging Biomarkers Across the Alzheimer’s Clinical Continuum
por: Moulinet, Inès, et al.
Publicado: (2022)

Exploring the combined effects of sleep apnea and APOE-e4 on biomarkers of Alzheimer’s disease
por: Turner, Arlener D., et al.
Publicado: (2023)

Salivary inflammatory biomarkers are predictive of mild cognitive impairment and Alzheimer’s disease in a feasibility study
por: McNicholas, Kym, et al.
Publicado: (2022)

Different Profiles of Spatial Navigation Deficits In Alzheimer’s Disease Biomarker-Positive Versus Biomarker-Negative Older Adults With Amnestic Mild Cognitive Impairment
por: Laczó, Martina, et al.
Publicado: (2022)

Editorial: Progress of Translational Medicine in Alzheimer's Disease
por: Zhang, Can, et al.
Publicado: (2022)

Associations of multiple visual rating scales based on structural magnetic resonance imaging with disease severity and cerebrospinal fluid biomarkers in patients with Alzheimer’s disease
por: Wan, Mei-dan, et al.
Publicado: (2022)

The Influence of 24-h Ambulatory Blood Pressure on Cognitive Function and Neuropathological Biomarker in Patients With Alzheimer's Disease
por: Li, Lixia, et al.
Publicado: (2022)

X chromosome-wide association study of quantitative biomarkers from the Alzheimer’s Disease Neuroimaging Initiative study
por: Wang, Kai-Wen, et al.
Publicado: (2023)

Polygenic Score Models for Alzheimer’s Disease: From Research to Clinical Applications
por: Zhou, Xiaopu, et al.
Publicado: (2021)

The multi-domain exercise intervention for memory and brain function in late middle-aged and older adults at risk for Alzheimer's disease: A protocol for Western–Eastern Brain Fitness Integration Training trial
por: Chang, Yu-Kai, et al.
Publicado: (2022)

Editorial: Translational advances in Alzheimer's, Parkinson's, and other dementia: Molecular mechanisms, biomarkers, diagnosis, and therapies, volume II
por: Jiang, Jiehui, et al.
Publicado: (2022)

The Relationship Between Cardiovascular Disease Risk Score and Postoperative Delirium: The PNDABLE Study
por: Wang, Jiahan, et al.
Publicado: (2022)

Editorial: Additive or synergistic impacts of sleep, circadian rhythm disturbances and other modifiable risk factors on established and novel plasma biomarkers of Alzheimer's disease pathology
por: Bubu, Omonigho M., et al.
Publicado: (2023)

Alzheimer’s disease and epilepsy: An increasingly recognized comorbidity
por: Yang, Fei, et al.
Publicado: (2022)

SCAD-Brain: a public database of single cell RNA-seq data in human and mouse brains with Alzheimer's disease
por: Li, Xin-Wen, et al.
Publicado: (2023)

Exploring the role of non-coding RNAs as potential candidate biomarkers in the cross-talk between diabetes mellitus and Alzheimer’s disease
por: Ghiam, Shokoofeh, et al.
Publicado: (2022)

Alzheimer’s disease biomarkers in patients with obstructive sleep apnea hypopnea syndrome and effects of surgery: A prospective cohort study
por: Kong, Weili, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bm6ej3lltd8rj4mgculgi4rg2e